DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

High Dose Nimodipine Treatment Adjunct - 1

Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders

Intervention: Nimodipine (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Steven Deutsch, M.D., Principal Investigator, Affiliation: Washington DC VA


The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Clinical Details

Official title: High Dose Nimodipine Pharmacotherapy Adjunct

Study design: Primary Purpose: Treatment

Primary outcome:

Stimulated and non-stimulated craving

Stimulated and non-stimulated withdrawal

Anxiety, depression

Heart rate


Minimum age: 22 Years. Maximum age: 45 Years. Gender(s): Both.


Please contact site for information.

Locations and Contacts

Washington DC VA, Washington, District of Columbia 20422, United States
Additional Information

Last updated: June 2, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017